Dana-Farber Cancer Institute

presented by
Daily

New male birth control options in the works

Women have been largely in charge of making sure unwanted pregnancies don’t happen unexpectedly due to the availability of various forms of contraception. While men have the obvious choice of using condoms or in extreme cases going for the snip (and there have been talks of a future pill-form for men), other potentially affective options […]

Channel

A whopping $53.1M Series B will help Syros Pharmaceuticals advance toward clinic for cancer

Gene regulation startup Syros Pharmaceuticals has raised a $53.1 million from 16 investors, according to regulatory filings. This financing round was led by “a large, Boston-based public investment firm,” also includes new investors Polaris Partners, Aisling Capital and Redmile Group. The current investors – Flagship Ventures, ARCH Venture Partners, WuXi PharmaTech Corporate Ventuer Fund and […]